Cytokine actions on the thyroid gland

Danish Medical Bulletin

Volumn 47, Issue 2, 2000, Pages 94-114

  Rasmussen, Åse Krogh ^a,b  

^a FREDERIKSBERG HOSPITAL   (Denmark)

^b Rigshospitalet   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; AUTOANTIBODY; CALCITONIN; CYTOKINE; GAMMA INTERFERON; HLA ANTIGEN; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIOTHYRONINE; LYMPHOTOXIN; THYROGLOBULIN; THYROID HORMONE; THYROID PEROXIDASE; THYROXINE; TUMOR NECROSIS FACTOR ALPHA;

AUTOIMMUNITY; CELL DIFFERENTIATION; CYTOKINE RELEASE; ENVIRONMENTAL FACTOR; GRAVES DISEASE; HASHIMOTO DISEASE; HORMONAL REGULATION; HYPOTHALAMUS HYPOPHYSIS SYSTEM; IMMUNOGENETICS; INFLAMMATION; PREGNANCY; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE; THYROID GLAND; THYROID PARAFOLLICULAR CELL; THYROTOXICOSIS;

ANIMALS; CELLS, CULTURED; CYTOKINES; HUMANS; SIGNAL TRANSDUCTION; THYROID GLAND; THYROID HORMONES; THYROIDITIS, AUTOIMMUNE;

EID: 0033994999     PISSN: 09078916     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (269)

1. Abraham LJ, French MAH, Dawkins RL Polymorphic MHC ancestral haplotypes affect the activity of tumour necrosis factor-alpha. Clin Exp Immunol 1993; 92: 14-18.
2. Adams DD, Fastier FN, Howie JB, Kennedy TH, Kilpatrick JA, Stewart RDH. Stimulation of the human thyroid by infusions of plasma containing LATS protector. J Clin Endocrinol Metab 1974; 39: 826-832.
3. Ajjan RA, Watson PF, Mcintosh RS, Weetman AP. Intrathyroidal cytokine gene expression in Hashimoto's thyroiditis. Clin Exp Immunol 1996; 105: 523-528.
4. Ajjan RA, Watson PF, Weetman AP Detection of IL-12, IL-13, and IL-15 messinger ribonucleic acid in the thyroid of patients with autoimmune thyroid disease. J Clin Endocrinol Metab 1997; 82: 666-669.
5. Akira S, Taga T, Kishimoto T. Interleukin-6 in biology and medicine. Adv Immunol 1993; 54: 1-78.
6. Ambesi-Impiombato FS, Parks LAM, Coon HG. Culture of hormone dependent functional epithelial cells from rat thyroids. Proc Natl Acad Sci 1980; 77: 3455-3459.
7. Arend WP. Interleukin-1 receptor antagonist. Adv Immunol 1993; 54: 167-227.
8. Arreaza G, Yoshikawa N, Mukuta T, Resetkova E, Barsuk A, Nishikawa M, Muallim C, Miller N, Jamieson C, Volpé R. Expression of intercellular adhesion molecule-1 on human thyroid cells from patients with autoimmune thyroid disease: study of thyroid xenografts in nude and severe combined immunodeficient mice and treatment with FK-506. J Clin Endocrinol Metab 1995; 80: 3724-3731.
9. Asakawa H, Miyagawa J-I, Hanafusa, Katsura H, Miyazaki A, Otsuka T, Nakagawa H, Yamagata K, Tajima K, Mashita K, Kono N, Tarui S. Interferon-γ reduces actin filaments and inhibits thyroid-stimulating hormone-induced formation of microvilli and pseudopods in mouse monolayer thyrocytes. Endocrinol 1990; 127: 325-329.
10. Asakawa H, Hanafusa T, Oda Y, Katsura H, Miyagawa J-I, Mashita K, Kono N, Tarui S. Human recombinant interleukin 1 inhibits TSH-stimulated morphological changes in thyroid follicles cultured as semiorgans. Acta Endocrinol (Copenh) 1991; 125: 80-85.
11. Asakawa H, Hanafusa T, Kobayashi T, Takai S, Kono N, Tarui S. Interferon-γ reduces the thyroid peroxidase content of cultured human thyrocytes and inhibits its increase induced by thyrotropin. J Clin Endocrinol Metab 1992; 74: 1331-1335.
12. Asakawa H, Hanafusa T, Kobayashi T, Fujita S, Takai S-I, Kono N, Matsuzawa Y. Effects of tumor necrosis factor-α on the thyroid peroxidase content, DR antigen expression, and number of microvilli in cultured human thyrocytes. Biomed Res 1993; 14: 5-11.
13. Asakawa H, Miyagawa J-I, Kobayashi T, Hanafusa T, Kuwajima M, Matsuzawa Y. Effects of interleukin-1β on scanning electron microscopic appearance and thyroid peroxidase content of human thyrocytes in monolayer culture. Immunopharm 1996; 34: 131-137.
14. Ashizawa K, Yamashita S, Tobinga T, Nagayama Y, Kimura H, Hirayu H, Izumi M, Nagataki S. Inhibition of human thyroid peroxidase gene expression by interleukin 1. Acta Endocrinol (Copenh) 1989a; 121: 465-469.
15. Ashizawa K, Yamashita S, Nagayama Y, Kimura H, Hirayu H, Izumi M, Nagataki S. Interferon-γ inhibits thyrotropin-induced thyroidal peroxidase gene expression in cultured human thyrocytes. J Clin Endocrinol Metab 1989b, 69: 475-477.
16. Atkins MB, Mier JW, Parkinson DR, Gould JA, Berkman EM, Kaplan MM. Hypothyroidism after treatment with interleukin-2 and lymphokine-activated killer cells. New Engl J Med 1988; 318: 1557-1563.
17. Auron PE, Warner JC, Webb AC, Cannon JG, Bernheim HA, McAdam KJPW, Rosenwasser LJ, LoPreste G, Mucci SF, Dinarello CA. Studies on the molecular nature of human interleukin 1. J Immunol 1987; 138: 1447-1456.
18. Aust G, Heuer M, Laue S, Lehmann I, Hofmann A, Heldin NE, Scherbaum WA. Expression of tumour necrosis factor-alpha (TNF-α) mRNA and protein in pathological thyroid tissue and carcinoma cell lines. Clin Exp Immunol 1996; 105: 148-154.
19. Badenhoop K, Schwarz G, Walfish PG, Drummond V, Usadel KH, Bottazo GF. Susceptibility to thyroid autoimmune disease: Molecular analysis of HLA-D region genes identifies new markers for goitrous Hashimoto's thyroiditis. J Clin Endocrinol Metab 1990; 71: 1131-1137.
20. Badenhoop K, Schwarz G, Schleusner H, Weetman AP, Recks S, Peters H, Bottazo GF, Usadel KH. Tumor necrosis factor β gene polymorphisms in Graves' disease. J Clin Endocrinol Metab 1992; 74: 187-291.
21. Baker JR, Saunders NB, Tseng YC, Wartofsky L, Burman KD. Seronegative Hashimoto thyroiditis with thyroid autoantibody production localized to the thyroid. Ann Intern Med 1988; 108: 26-30.
22. Barlow ABT, Wheatcroft N, Watson P, Weetman AP. Association of HLA-DQA1*0501 with Graves' disease in English Caucasian men and women. Clin Endocrinol 1996; 44: 73-77.
23. Bartalena L, Brogioni S, Grasso L, Martino E. Increased serum interleukin-6 concentration in patients with subacute thyroiditis: relationship with concomitant changes in serum T4-binding globulin concentration. J Endocrinol Invest 1993; 16: 213-218.
24. Bartalena L, Grasso L, Brogioni S, Martino E. Interleukin 6 effects on the pituitary-thyroid axis in the rat. Eur J Endocrinol 1994a; 131: 302-306.
25. Bartalena L, Brogioni S, Grass L, Rago T, Vitti P, Pinchera A, Martino E. Interleukin 6: a marker of thyroid destructive processes? J Clin Endocrinol Metab 1994b; 79: 1424-1427.
26. Bartalena L, Grasso L, Brogioni S, Aghini-Lombardi F, Braverman LE, Martino E. Serum interleukin-6 in amiodarone-induced thyrotoxicosis. J Clin Endocrinol Metab 1994c; 78: 423-427.
27. Bartalena L, Brogioni S, Grasso L, Velluzzi F, Martino E. Relationship of the increased serum interleukin-6 concentration to changes of thyroid function in nonthyroidal illness. J Endocrinol Invest 1994d; 17: 269-274.
28. Baudin E, Marcellin P, Pouteau M, Colas-Linhart N, Le Floch J-P, Lemmonier C, Benhamou J-P, Bok B. Reversibility of thyroid dysfunction induced by recombinant alpha interferon in chronic hepatitis C. Clin Endocrinol 1993; 39: 657-661.
29. Beach JE, Smallridge RC, Kinzer CA, Bernton EW, Holaday JW, Fein HG. Rapid release of multiple hormones from rat pituitaries perifused with recombinant interleukin-1. Life Sci 1989; 44: 1-7.
30. Bech K, Lumholtz B, Nerup J, Thomsen M, Platz P, Ryder LP, Svejgaard A, Siersbæk-Nielsen K, Hansen JM, Larsen JH. HLA antigens in Graves' disease. Acta Endocrinol 1977a; 86: 510-516.
31. Bech K, Clemmensen O, Larsen JH, Bendixen G. Thyroid disease and Yersinia. Lancet 1977b; 1: 1060-1061.
32. Bellur S, Tahara K, Saji M, Grollman EF, Kohn LD. Repeatedly passes FRTL-5 rat thyroid cells can develop insulin and insulin-like growth factor-I-sensitive cyclooxygenase and prostaglandin E2 isomerase-like activities together with altered basal and thyrotropin-responsive thymidine incorporation into DNA. Endocrinol 1990; 127: 1526-1540.
33. Bendtzen K, Mandrup-Poulsen T, Nerup J, Nielsen JH, Dinarello CA, Svenson M. Cytotoxicity of human pI 7 interleukin-1 for pancreatic islets of Langerhans. Science 1986; 232: 1545-1547.
34. Bendtzen K, Rasmussen ÅK, Bech K, Feldt-Rasmussen U, Buschard K. Pathogenic role of interleukin 1 and tumor necrosis factor in autoimmune endocrine diseases. Clin Immunol Newslet 1988; 9: 72-74.
35. Bendtzen K. Immune hormones (cytokines); pathogenic role in autoimmune rheumatic diseases and endocrine diseases. Autoimmunity 1989; 2: 177-189.
36. Bendtzen K Cytokines and natural regulators of cytokines. Immunol Lett 1994; 43: 111-123.
37. Bernard NF, Ertug F, Margolese H. High incidence of thyroiditis and antithyroid autoantibodies in NOD mice. Diabetes 1992; 41: 40-46
38. Bernton EW, Beach JE, Holaday JW, Smallridge RC, Fein HG. Release of multiple hormones by a direct action of interleukin-1 on pituitary cells. Science 1987; 238: 519-521.
39. Berris B, Feinman SV. Thyroid dysfunction and liver injury following alpha-interferon treatment of chronic viral hepatitis. Dig Dis Sci 1991, 36: 1657-1660.
40. Beutler BA, Milsark IW, Cerami A. Cachectin/tumor necrosis factor: production, distribution and metabolic fate in vivo. J Immunol 1985; 135: 3972-3977.
41. Blakemore AIF, Watson PF, Weetman AP, Duff GW. Association of Graves' disease with an allele of the interleukin-1 receptor antagonist gene. J Clin Endocrinol Metab 1995; 80: 41-45.
42. Boehm BO, Schifferdecker E, Kuehnl P, Schöffling K. Linkage of HLA-DRβ specific restriction fragment length polymorhisms with Graves' disease. Acta Endocrinol (Copenh) 1988; 119: 251-256.
43. Boelen A, Platvoetter Schiphorst MC, Wiersinga WM. Association between serum interleukin-6 and serum 3-,5,3′-triiodothyronine in non-thyroidal illness. J Clin Endocrinol Metab 1993; 77: 1695-1699.
44. Boelen A, Maas MAW, Lowik CWGM, Platvoet MC, Wiersinga WM. Induced illness in interleukin-6 (IL-6) knock-out mice: a causal role of IL-6 in the development of the low 3,5,3′-triiodothyronine syndrome. Endocrinol 1996; 137: 5250-5254.
45. Boelen A, Platvoetter Schiphorst MC, Wiersinga WM. Immunoneutralization of interleukin-1, tumor necrosis factor, interleukin 6 or interferon does not prevent the LPS-induced sick euthyroid syndrome in mice. J Endocrinol 1997; 153: 115-122.
46. Burman P, Tötterman TH, Öberg, Karlsson FA. Thyroid autoimmunity in patients on long term therapy with leukocyte-derived interferon. J Clin Endocrinol Metab 1986; 63: 1086-1090.
47. Buscerna M, Todd I, Deuss U, Hammond L, Mirakian R, Pujol-Borrell R, Bottazo GF. Influence of tumor necrosis factor-α on the modulation by interferon-γ of HLA Class II molecules in human thyroid cells and its effect on interferon-γ binding. J Clin Endocrinol Metab 1989; 69: 433-439.
48. Carrel A, Burrows MT. Cultivation of adult tissues and organs outside of the body. J Amer Med Assoc 1910; 55: 1379-1381.
49. Ceretti DP, Kozlosky CJ, Mosley B, Nelson N, Van Ness K, Greensteet TA, March CJ, Kronheim SR, Druck T, Cannizzaro LA, Huebner K, Black RA. Molecular cloning of the interleukin-1β converting enzyme. Science 1992; 256: 97-100.
50. Chen GE, Pekary AE, Hershman JM. Aging of FRTL-5 rat thyroid cells causes sensitivity to cytotoxicity induced by tumor necrosis factor-α. Endocrinol 1992; 131: 863-870.
51. Chopra IJ, Sakane S, Teco GNC. A study of the serum concentration of tumor necrosis factor-α in thyroidal and non-thyroidal illnesses. J Clin Endocrinol Metab 1991; 72: 1113-1116.
52. Ciampolillo A, Mirakain R, Schulz T, Vittoria M, Buscema M, Pujol-Borrell R, Botazzo GF. Retrovirus-like sequences in Graves' disease: implications for human auto-immunity. Lancet 1989; 2: 1096-1099.
53. Cohen SB, Weetman AP. Characterization of different types of experimental auto-immune thyroiditis in the Buffalo strain rat. Clin Exp Immunol 1987; 69: 25-32.
54. Cohen SB, Weetman AP. Activated interstitial and intraepithelial thyroid lymphocytes in autoimmune thyroid disease. Acta Endocrinol 1988; 119: 161-166.
55. Corssmit EPM, Heyligenberg R, Endert E, Sauerwein HP, Romijn JA. Acute effects of interferon-α administration on thyroid hormone metabolism in healthy men. J Clin Endocrinol Metab 1995; 80: 3140-3144.
56. Cuddihy RM, Bahn RS. Lack of an association between alleles of interleukin-1α and interleukin-1 receptor antagonist genes and Graves' disease in a North American caucasian population. J Clin Endocrinol Metab 1996; 81: 4476-4478.
57. Dalbøge H, Bayne S, Christensen T, Hejnass KR. Cloning and expression of an interleukin-1β precursor and its conversion to interleukin-1β. FEBS Lett 1989; 246: 89-93.
58. Davies TF, Platzer M, Schwartz AE, Friedman EW. Short- and long-term evaluation of normal and abnormal human thyroid cells in monolayer culture. Clin Endocrinol 1985; 23: 469-79.
59. Davies PH, Black EG, Sheppard MC, Franklyn JA. Relation between serum interleukin-6 and thyroid hormone concentrations in 270 hospital in patients with non-thyroidal illness. Clin Endocrinol 1996; 44: 199-205.
60. Dayan CM, Feldmann M, Rapoport B, Londei M. Autoimmune thyroiditis and targeted anti-T cell immunotherapy in man. Autoimmunity 1992; 11: 189-198.
61. Deuss U, Buscema M, Botazzo GF. Rehabilitation of cytokines in thyroid autoimmunity: are they only excerting negative effects? In: The thyroid 1988. Nagataki S, Torizuka K (eds.) Amsterdam: Excerpta Medica 1988; 44-50.
62. Deuss U, Buscema M, Schumacher H, Winkelmann W. In vitro effects of tumor necrosis factor-α in human thyroid follicular cells. Acta Endocrinol 1992; 127: 220-225.
63. Diamant M, Kayser L, Rasmussen ÅK, Bendtzen K. Interleukin-6 production by thyroid epithelial cells. Enhancement by interleukin-1. Autoimmunity 1991; 11. 21-26.
64. Dinarello CA. Interleukin 1 and interleukin-1 antagonism. Blood 1991; 77: 1627-1652.
65. Dinarello CA. Biological basis for interleukin-1 in disease. Blood 1996; 87: 2095-2147.
66. Dubuis JM, Dayer JM, Siegrist-Kaiser CA, Burger AG. Human recombinant interleukin-1β decreases plasma thyroid hormone and thyroid stimulating hormone levels in rats. Endocrinol 1988; 123: 2175-2181.
67. Eggo MC, Bachrach LK, Fayet G, Errick J, Kudlow JE, Cohen MF, Burrow GN. The effects of growth factors and serum on DNA synthesis and differentiation in thyroid cells in culture. Mol and Cell Endocrinol 1984; 38: 141-150.
68. Eizirik DL, Tracey DE, Bendtzen K, Sandler S. An interleukin-1 receptor antagonist protein protects insulin-producing beta cells against suppressive effects of interleukin-1β Diabetol 1991; 34: 445-448.
69. Enomoto T, Sugawa H, Kosugi S, Inoue D, Mori T, Imura H. Prolonged effects of recombinant human interleukin-1α on mouse thyroid function. Endocrinol 1990; 127: 2322-2327.
70. Estevez R, van Sande J, Dumont J. Nitric oxide as a signal in thyroid. Mol Cell Endocrinol 1992; 90: R1-R3.
71. Ewins DL, Rossor MN, Butler J, Roques PK, Mullan MJ, McGregor AM. Association between autoimmune thyroid disease and familial Alzheimer's disease. Clin Endocrinol (Oxf) 1991; 35: 93-96.
72. Farid NR, Stone E, Johnson G. Graves' disease and HLA: Clinical and epidemiological associations. Clin Endocrinol 1980; 13: 535-544.
73. Farid NR, Bear JC. The human major histocompatibility complex and endocrine disease. Endocrine Reviews 1981; 2: 50-86.
74. Fentiman IS, Thomas BS, Balkwill FR, Rubens RD, Hayward JL. Primary hypothyroidism associated with interferon therapy of breast cancer. Lancet 1985; 1166.
75. Fujii T, Sato K, Ozawa M, Kasono K, Imamura H, Kanaji Y, Tsushima T, Shizume K. Effect of interleukin-1 (IL-1) on thyroid hormone metabolism in mice: stimulation by IL-1 of iodothyronine 5′-deiodinating activity (Type 1) in the liver. Endocrinol 1989; 124: 167-174.
76. Gisslinger H, Gilly B, Wolosczuk W, Mayr WR, Havelec L, Linkesch W. Thyroid autoimmunity and hypothyroidism during long-term treatment with recombinant interferon-alpha. Clin Exp Immunol 1992; 90: 363-367.
77. Gonzalez MC, Riedel M, Rettori V, Yu WH, McCann SM. Effect of recombinant human γ-interferon on the release of anterior pituitary hormones. Prog Neuroendocrinol Immunol 1990; 3: 49-54.
78. Graves P, Neufeld DS, Davies TF. Differential cytokine regulation of MHC Class II and thyroglobulin mRNAs in rat thyroid cells. Mol Endocrinol 1989; 3: 758-762.
79. Grubeck-Loebenstein B, Buchan G, Chantry D, Kassal H, Londei M, Pirich K, Barrett K, Turner M, Waldhausl W, Feldmann M. Analysis of intrathyroidal cytokine production in thyroid autoimmune disease: thyroid follicular cells produce interleukin-1α and interleukin-6. Clin Exp Immunol 1989; 77: 324-330.
80. Grumet FC, Payne RO, Konishi J, Kriss JP. HLA-antigens as markers for disease susceptibility and utoimmunity in Graves' disease. J Clin Endocrinol Metab 1974; 39: 1115-1119.
81. Guerin V, Todd I, Hammond LJ, Botazzo GF. Suppression of HLA class II expression on thyrocytes by interferon-α. Clin Exp Immunol 1990, 79: 341-345.
82. Hanafusa T, Pujol-Borrell R, Chiovato L, Russell RCG, Doniach D, Bottazzo GF. Aberrant expression of HLA-DR antigen on thyrocytes in Graves' disease: relevance for autoimmunity. Lancet 1983: 1111-1115.
83. Harris T, Creed F, Brugha TS. Stressful life events and Graves' disease. Br J Psychiatry 1992; 161: 535-541.
84. Hashimoto H, Igarashi N, Yachie A, Miyawaki T, Sato T. The relationship between serum levels of interleukin-6 and thyroid hormone in children with acute respiratory infection. J Clin Endocrinol Metab 1994; 78: 288-291.
85. Hashimoto H, Igarashi N, Miyawaki T, Sato T. Effects of tumor necrosis factor-α, interleukin-1β, and interleukin-6 on type 1 iodothyronine 5′-delodination in rat thyroid cell line FRTL-5. J Interferon and Cytokine Res 1995; 15: 367-375.
86. Hawkins BR, Lam KSL, Ma JTC, Wang C, Yeung RTT. Strong association between HLA DRw9 and Hashimoto's thyroiditis in Southern Chinese. Acta Endocrinol (Copenh) 1987; 114: 543-546.
87. Heinrich PC, Castell JV, Andus T. Interleukin-6 and the acute phase response. Biochem J 1990; 265: 621-636.
88. Helquist S, Polla BS, Johannesen J, Nerup J. Heat shock protein induction in rat pancreatic islets by recombinant human interelukin 1β. Diabetol 1991; 34: 150-156.
89. Hermus RMM, Sweep CGJ, Meer van der MTM, Ross HA, Smals AGH, Benraad TJ, Kloppenborg PWC. Continuous infusion of interleukin-1β induces a non-thyroidal illness syndrome in the rat. Endocrinol 1992; 131: 2139-2146.
90. Heuer M, Aust G, Ode-Hakim S, Scherbaum WA. Different cytokine mRNA profiles in Graves' disease, Hashimoto's thyroiditis, and nonautoimmune thyroid disorders determined by quantitative reverse transcriptase polymerase chain reaction (RT-PCR). Thyroid 1996; 6: 97-106.
91. Heufelder AE, Goellner JR, Wenzel BE, Bahn RS. Immunohistochemical detection and localization of a 72-kilodalton heat shock protein in autoimmune thyroid disease. J Clin Endocrinol Metab 1991; 74: 724-731.
92. Hidaka Y, Tamaki H, Iwatani Y, Tada H, Mitsuda M, Amino N. Prediction of post-partum onset of Graves' thyrotoxicosis by measurement of thyroid stimulating antibody in early pregnancy. Clin Endocrinol 1994; 41: 15-20.
93. Hoekman K, Von Blomberg-van der Flier, BME, Wagstaff J, Drexhage HA, Pinedo HM. Reversible thyroid dysfunction during treatment with GM-CSF. Lancet 1991; 338: 541-542
94. Honda KL, Tamai H, Morita T, Kuma K, Nishimura Y, Sasazuki T. Hashimoto's thyroiditis and HLA in Japanese. J Clin Endocrinol Metab 1989; 69: 1268-1273.
95. Honegger J, Spagnoli A, D'urso R, Navarra P, Tsagarakis S, Besser GM, Brossman AB. Interleukin-1β modulates the acute release of growth hormone-releasing hormone and somatostatin from rat hypothalamus in vitro, whereas tumour necrosis factor and interleukin-6 have no effect. Endocrinol 1991; 129: 1275-1282.
96. Huber GK, Davies TF. Human fetal thyroid cell growth in Vitro: System characterization and cytokine inhibition. Endocrinol 1990; 126: 869-875.
97. Humphrey M, Baker JR, Carr FE, Wartofsky L, Mosca J, Drabick JJ, Djuh YY, Burman KD. Absence of retroviral sequences in Graves' disease. Lancet 1991; 337: 17-18.
98. Inoue D, Sato K, Enomoto T, Sugawa H, Maeda M, Inoko H, Tsuji K, Mori T, Imura H. Correlation of HLA types and clinical findings in Japanese patients with hyperthyroid Graves' disease: evidence indicating the existence of four subpopulations. Clin Endocrinol 1992; 36: 75-82.
99. Iwamoto M, Sakihama T, Kimura N, Tasaka K, Onaya T, Augmented interleukin 6 production by rat thyrocytes (FRTL5): Effect of interleukin 1β and thyroid-stimulating hormone. Cytokine 1991; 3: 345-349.
100. Jacobs EL, Clare-Salzler MJ, Chopra IJ, Figlin RA. Thyroid function abnormalities with the chronic outpatient administration of recombinant interleukin-2 and recombinant interferon-alpha. J Immunotherapy 1991; 10: 448-455.
101. Kasai K, Hiraiwa M, Emoto T, Kuroda Y, Hattori Y, Mochizuki Y, Nakamura T, Shimoda S-I. Presence of high affinity receptor for interleukin-1 (IL-1) on cultured porcine thyroid cells. Horm Metabol Res 1990; 22: 75-79.
102. Kasai K., Hattori Y, Nakanishi N, Manaka K, Banba N, Motohashi S, Shimoda S-I. Regulation of inducible nitric oxide production by cytokines in human thyrocytes in culture. Endocrinol 1995; 136: 4261-4270.
103. Kawabe Y, Eguchi K, Shimomura C, Mine M, Otsubo T, Ueki Y, Tezuka H, Nakao H, Kawakami A, Migita K, Yamashita S, Matsunaga A, Ishikawa N, Ito K, Nagataki S. Interleukin-1 production and action in thyroid tissue. J Clin Endocrinol Metab 1989; 68: 1174-1183.
104. Kawakami Y, Kuzuya N, Watanabe T, Uchiyama Y, Yamashita K. Induction of experimental thyroiditis in mice by recombinant interferon γ administration. Acta Endocrinol 1990; 122: 41-48.
105. Kayser L, Olsen BE, Høyer PE. Quantitative cytochemical demonstration of intracellular thyroglobulin in cultured human thyrocytes. Effects of fixatives, TSH and interleukin-1β. Histochemical Journal 1991; 23: 235-240.
106. Kayser L, Broholm H, Francis D, Perrild H, Olsen BE, Bendtzen K, Høyer PE. Immunocytochemical localisation of interleukin-1α and interleukin-6 in thyroid tissues from patients with neoplastic or autoimmune thyroid disorders. Autoimmunity 1995; 20: 75-82.
107. Kayser L, Broholm H, Francis D, Perrild H, Olsen BE, Bendtzen K, Høyer PE. Immunocytochemical localisation of tumor necrosis factor α in thyroid tissues from patients with neoplastic or autoimmune thyroid disorders. Autoimmunity 1996; 23: 91-97.
108. Kennedy RL, Jones TH. Cytokines in endocrinology: their roles in health and in disease. J Endorinol 1991; 129: 167-178.
109. Kennedy RL, Jones TH, Davies R, Justice SK, Lemoine NR. Release of interleukin-6 by human thyroid epithelial cells immortalized by simian virus 40 DNA transfection. J Endocrinol 1992; 133: 477-482.
110. Kimura H, Yamashita S, Namba H, Tominaga T, Tsuruta M, Yokoyama N, Izumi M, Nagataki S. Interleukin-1 inhibits human thyroid carcinoma cell growth. J Clin Endocrinol Metab 1992; 75: 596-602.
111. Kishimoto T, Akira S, Taga T. Interleukin-6 and its receptor: a paradigm for cytokines. Science 1992; 258: 593-597.
112. Knudsen PJ, Dinarello CA, Strom TB. Purification and characterization of a unique human interleukin 1 from the tumor cell line U937. J Immunol 1986; 136: 3311-3316.
113. Kostura MJ, Tocci MJ, Limjuco G, Chin J, Cameron P, Hillman AG, Chartrain NA, Schmidt JA. Identification of a monocyte specific pre-interleukin 1β convertase activity. Proc Natl Acad Sci USA 1989; 86: 5227-5231.
114. Kraiem Z, Sobel E, Sadeh O, Kinarty A, Lahat N. Effects of γ-interferon on DR antigen expression, growth, 3,5,3′-triiodothyro-nine secretion, iodide uptake, and cyclic adenosine 3′,5′-monophosphate accumulation in cultured human thyroid cells. J Clin Endocrinol Metab 1990; 71: 817-824.
115. Kralem Z, Sadeh O, Yosef M. Iodide uptake and organification, tri-iodothyronine secretion, cyclic AMP accumulation and cell proliferation in an optimized system of human thyroid follicles cultured in collagen gel suspended in serum-free medium. J Endocrinol 1991; 131: 499-506.
116. Kung AW, Lau KS. Interleukin-1 beta modulates thyrotropin-induced thyroglobulin mRNA transcription through 3′,5′-cyclic adenosine monophosphate. Endocrinol 1990a; 127: 1369-1374.
117. Kung AW, Lau KS. Interferon-γ inhibits thyrotropin-induced thyroglobulin gene transcription in cultured human thyrocytes. J Clin Endocrinol Metab 1990b; 70: 1512-1517.
118. Kung AWC, Jones BM, Lai CL. Effects of interferon-γ therapy on thyroid function, T-lymphocyte subpopulations and induction of autoantibodies. J Clin Endocrinol Metab 1990c; 71; 1230-1234.
119. Kung AWC, Lai CL, Wong KL, Tam CF. Thyroid functions in patients treated with interleukin-2 and lymphokine-activated killer cells. Quart J Med 1992a; 297: 33-42.
120. Kung AWC, Ma L, Lau KS. The role of interferon-gamma in lymphocytic thyroiditis: its functional and pathological effect on human thyrocytes in culture. Clin Exp Immunol 1992b; 87: 261-265.
121. Kung AWC, Lau KS, Wong NS. Interferon-γ increases intracellular calcium and inositol phosphates in primary human thyroid cell culture. Endocrinol 1995; 136: 5028-5033.
122. Lazarus JH, Hall R, Othman S, Parkes AB, Richards CJ, McGulloch B, Harris B. The clinical spectrum of postpartum thyroid disease. Quart J Med 1996; 89: 429-435.
123. Lidman K, Eriksson U, Nornerg R, Fagraeus A. Indirect immunofluorescence staining of human thyroid by antibodies occurring in Yersinia enterocolitica infections. Clin Exp Immunol 1976; 23: 429-435.
124. Lyson K, Milenkovic L, McCann SM. The stimulatory effect of interleukin-6 on corticotrophin-releasing hormone and thyrotropin-releasing hormone release in vitro. Neuroendocrinol 1991; 4: 161-165.
125. Lyson K, McCann SM. The effect of interleukin-6 on pituitary hormone release in vivo and in vitro. Neuroendocrinol 1991; 54. 262-266.
126. Malthiery Y, Lissitzky S. Primary structure of human thyroglobulin deduced from the sequence of its 8448-base complementary DNA. Eur J Biochem 1987; 105: 491-498.
127. Mandrup-Poulsen T, Nerup J, Reimers JI, Pociot F, Andersen HU, Karlsen AE, Bjerre U, Bergholt R. Cytokines and the endocrine system. II. Roles in substrate metabolism, modulation of thyroidal and pancreatic endocrine cell functions and autoimmune diseases. Eur J Endocrinol 1996; 134: 21-30.
128. Manglabruks A, Cox N, De Groot LJ, Genetic factors in autoimmune thyroid disease analyzed by restriction fragment length polymorphisms of candidate genes. J Clin Endocrinol Metab 1991; 73: 236-244.
129. Massart C, Gibassier J, Genetet N, Raoul ML, Baron M, Le Gall F, Lucas C. Effect of lymphocytes on hormonal secretion by autologous thyrocytes cultured in monolayers. J Mol Endocrinol 1996; 17: 185-195.
130. Matsunaga M, Eguchi K, Fukuda T, Kurata A, Tezuka H, Shimomura C, Otsubo T, Ishikawa N, Ito K, Nagataki S. Class II major histocompatibility complex antigen expression and cellular interactions in thyroid glands of Graves' disease. J Clin Endocrinol Metab 1986; 62: 723-728.
131. Matsunaga M, Eguchi K, Fukuda T, Tezuka H, Ueki Y, Kawabe Y, Shimomura C, Otsubo T, Ishikawa N, Ito K, Nagataki S. The effects of cytokines, antithyroidal drugs and glucocorticoids on phagocytosis by thyroid cells. Acta Endocrinol (Copenh) 1988; 119: 413-419.
132. McLachlan SB, Rapoport B. The molecular biology of thyroid peroxidase: cloning, expression and role as autoantigen in autoimmune thyroid disease. Endocr Rev 1992; 13: 192-206.
133. McLachlan SM, Pegg CAS, Atherton MC, Middleton SL, Dickinson A, Clark F, Rees Smith B. The thyroid microenvironment in autoimmune thyroid disease: Effects of TSH and lymphokines on thyroid lymphocytes and thyroid cells. Acta Endocrinol (Copenh) 1987; Suppl 281: 125-132.
134. Migita K, Eguchi K, Otsubo T, Kawakami A, Nakao H, Ueki Y, Shimomura C, Kurata A, Fukuda T, Matsunaga M, Ishikawa N, Ito K, Nagataki S. Cytokine regulation of HLA on thyroid cells. Clin Exp Immunol 1990; 82: 548-552.
135. Milenkovic L, Rettori V, Snyder GD, Beutler B, McCann SM. Cachectin alters anterior pituitary hormone release by a direct action in vitro. Proc Natl Acad Sci USA 1989; 86: 2418-2422.
136. Millatt LJ, Jackson R, Williams BC, Whitley GStJ. Nitric oxide stimulates cyclic GMP in human thyrocytes. J Mol Endocrinol 1993; 10: 163-169.
137. Mine M, Tramontano D, Chin WC, Ingbar SH. Interteukin 1 stimulates thyroid cell growth and increases the concentration of the c-myc proto-oncogene mRNA in thyroid follicular cells in culture. Endocrinol 1987; 120: 1212-1214.
138. Minelli R, Girasole G, Pedrazzoni M, Giuliani N, Schianchi C, Giuberti T, Braverman LE, Salvi M, Roti E. Lack of increased serum interleukin-6 and soluble IL-6 receptor concentrations in patients with thyroid diseases following recombinant human interferon α therapy. J Invest Med 1996; 44: 370-374.
139. Misaki T, Tramontano D, Ingbar SH. Effects of rat γ- and non-γ-interferons on the expression of Ia antigen, growth, and differentiated functions of FRTL5 cells. Endocrinol 1988; 123: 2849-2857.
140. Mooradien AD, Reed RL, Osterweil D, Sciffman R, Scuderi P. Decreased serum triiodo-thyronine is associated with increased concentrations of tumor necrosis factor. J Clin Endocrinol Metab 1990; 71: 1239-1242.
141. Mosley B, Dower SK, Gillis S, Cosman D. Determination of the minimum polypeptide lengths of the functionally active sites of human interleukin 1α and 1β. Proc Natl Acad Sci USA 1987; 84: 4572-4576.
142. Motohashi S, Kasai K, Banba N, Hattori Y, Shimoda S-I. Nitric oxide inhibits cell growth in cultured human thyrocytes. Life Sci 1996; 59: 227-234.
143. Murai H, Murakami S, Ishida K, Sugawara M. Elevated serum interleukin-6 and decreased thyroid hormone levels in postoperative patients and effects of IL-6 on thyroid cell function in vitro. Thyroid 1996; 6: 601-606.
144. Nabozny GH, Kong Y-CM. Circumvention of the induction of resistance in murine experimental autoimmune thyroiditis by recombinant IL-1β. J Immunol 1992; 149: 1086-1092.
145. Nagayama Y, Izumi M, Aschizawa K, Kiriyama T, Yokoyama N, Morita S, Ohtakara S, Fukuda T, Eguchi K, Morimoto I, Okamoto S, Ishikawa N, Ito K, Nagataki S. Inhibitory effect of interferon-γ on the response of human thyrocytes to thyrotropin stimulation: relationship between the response to TSH and the expression of DR antigen. J Clin Endocrinol Metab 1987; 64: 949-953.
146. Nerup J. On the pathogenesis of IDDM. Diabetol 1994; 37 (Suppl 2): S82-S89.
147. Nielsen PK, Rasmussen ÅK, Butters R, Feldt-Rasmussen U, Bendtzen K, Diaz R, Brown EM, Olgaard K. Inhibition of PTH secretion by interleukin-1β in bovine parathyroid glands in vitro is associated with an up-regulation of the calcium-sensing receptor mRNA. Biochem Biophys Res Comm 1997; 238: 880-885.
148. +2 is polarized. Eur J Cell Biol 1991; 56: 295-307.
149. Nilsson M, Husmark J, Nilsson B, Tisell L-E, Ericson LE. Primary culture of
150. human thyrocytes in Transwell bicameral chamber: thyrotropin promotes polarization and epithelial barrier function. Europ J Endocrinol 1996; 135: 469-480.
151. Nilsson M, Husmark J, Bjorkman U, Ericson LE. Cytokines and thyroid epithelial integrity, interleukin-1 alpha induces dissociation of the junctional complex and paracellular leakage in filter-cultured human thyrocytes. J Clin Endocrinol Metab 1998; 83: 945-952.
152. Nishikawa T, Yamashita S, Namba H, Usa T, Tominaga T, Kimura H, Izumi M, Nagataki S. Interferon-γ inhibition of human thyrotropin receptor gene expression. J Clin Endocrinol Metab 1993; 77: 1084-1089.
153. Nishida T, Hirato T, Nishino N, Mizuno K, Sekiguchi Y, Takano M, Kawai K, Nakai S, Yoshikatsu H. Clining of the cDNAs for rat interelukin-1α and α. In: Monokines and other non-lymphocytic cytokines. Powanda MC, Oppenheim JJ, Kluger MJ, Dinarello CA (eds.), Alan R. Liss, Inc., 1988: 73-78.
154. Nishiyama S, Takada K, Tada H, Takano T, Amino N. Effect of interleukin-6 on cell proliferation of FRTL-5 cells. Biochem Biophys Res Comm 1993; 192: 319-323.
155. Nolte A, Bechtner G, Rafferzeder M, Gärtner R. Interleukln-1 beta (IL-1β) binds to intact porcine thyroid follicles, decreases iodide uptake but has no effect on cAMP formation or proliferation. Horm Metab Res 1994; 26: 413-418.
156. Ollis CA, Fowles A, Brown BL, Munro DS, Tomlinson S. Human thyroid cells in monolayer retain the ability to secrete tri-iodothyronine in response to thyrotrophin. J Endocrinol 1985; 104: 285-290.
157. Ongphiphadhanakul B, Fang SL, Tang K-T, Patwardhan NA, Braverman LE. Tumor necrosis factor-α decreases thyrotropin-induced 5′-deiodinase activity in FRTL-5 thyroid cells. Europ J Endocrinol 1994; 130: 502-507.
158. Ozawa M, Sato K, Han DC, Kawakami M, Tsushima T, Shizume K. Effects of tumor necrosis factor-α/cachectin on thyroid hormone metabolism in mice. Endocrinol 1988; 123: 1461-1467.
159. Pang X-P, Hershman JM, Chung M, Pekary AE. Characterization of tumor necrosis factor-alpha receptors in human and rat thyroid cells and regulation of the receptors by thyrotropin. Endocrinol 1989a; 125: 1783-1788.
160. Pang X-P, Hershman JM, Mirell CJ, Pekary AE. Impairment of hypothalamic-pituitary-thyroid function in rats treated with human recombinant tumor necrosis factor-α (cachectin). Endocrinol 1989b; 125: 76-84.
161. Pang X-P, Hershman JM, Smith V, Pekary AE, Sugawara M. The mechanism of action of tumor necrosis factor-α and interleukin-1 on FRTL-5 cells. Acta Endocrinol (Copenh) 1990; 123: 203-210.
162. Paschke R, Kist A, Jäniche R, Eck T, Velu T, Usadel KH. Lack of intrathyroidal tumor necrosis factora in Graves' disease. J Clin Endocrinol Metab 1993; 76: 97-102.
163. Patwardhan NA, Lombardi A. Effect of tumor necrosis factor on growth and function in FRTL5 cells. Surgery 1991; 110: 972-977.
164. Payami H, Jor S, Farid NR, Stenszky V, Chan SH, Yeo PPB, Cheah JS, Thomson G. Relative predispositional effects (RPEs) of marker alleles with disease: HLA-DR alleles and Graves disease. Am J Hum Genet 1989; 45: 541-546.
165. Pekary AE, Berg L, Santini F, Chopra I, Hershman JM. Cytokines modulate
166. Philips D, McLachlan S, Stephenson A, Roberts D, Moffitt S, McDonald D, Ad'Hiah A, Stratton A, Young E, Clark F, Beever K, Bradbury J, Smith BR. Autosomal dominant transmission of autoantibodies to thyroglobulin and thyroid peroxidase. J Clin Endocrinol Metab 1990; 70: 742-746.
167. Piccinini LA, Mackenzie WA, Platzer M, Davies T. Lymphokine regulation of HLA-DR gene expression in human thyroid cell monolayers. J Clin Endocrinol Metab 1987; 64: 543-548.
168. Pichert G, Jost LM, Zöbeti L, Odermatt B, Pedio G, Stahel RA. Thyroiditis after treatment with interleukin-2 and interferon α-2a. Br J Cancer 1990; 62: 100-104.
169. Platzer M, Neufeld DS, Piccinini, Davies TF. Induction of rat thyroid cell MHC class II antigen by thyrotropin and γ-interferon. Endocrinol 1987; 121: 2087-2092.
170. Poth M, Tseng Y-U, Wartofsky L. Inhibition of TSH activation of human cultured thyroid cells by tumor necrosis factor: An explanation for decreased thyroid function in systemic illness? Thyroid 1991; 1: 3: 235-240.
171. Pulverthaft RJV, Davies JR, Weiss L, Wilkinson JH. Studies on tissue cultures of human pathological thyroids. J Path Bact 1959; 77: 19-32.
172. Radosavljevic VR, Jankovic SM, Marinkovic JM. Stressful life events in the pathogenesis of Graves' disease. Eur J Endocrinol 1996; 134: 699-701.
173. Rasmusssen ÅK, Bech K, Feldt-Rasmussen U, Poulsen S, Holten I, Ryberg M, Dinarello CA, Siersbæk-Nielsen K, Friis T, Bendtzen K. Interleukin-1β affects the function of cultured human thyroid cells. Allergy 1988; 43: 435-441.
174. Rasmussen ÅK, Kayser L, Bech K, Feldt-Rasmussen U, Perrild H, Bendtzen K. Differential effects of interleukin 1α and 1β on cultured human and rat thyroid cells. Acta Endocrinol 1990, 122, 4: 520-526.
175. Rasmussen ÅK, Kayser L, Bech K, Feldt-Rasmussen U, Perrild H, Bendtzen K. The influence of interleukin 6 on the function of secondary cultures of human thyrocytes. Acta Endocrinol 1991, 124: 577-582.
176. Rasmussen ÅK, Kayser L, Feldt-Rasmussen U, Bendtzen K. Influence of TNF-α, TNF-β and IFN-γ, separately and combined with IL-1β, on the function of cultured human thyroid cells. J Endocrinol 1994a; 143: 359-365.
177. Rasmussen AK, Di Marco R, Diamant M, Feldt-Rasmussen U, Bendtzen K. Nitric oxide production is not involved in the effects of interleukin-1β on cAMP, thyroglobulin and interleukin-6 in TSH-stimulated human thyroid cells. Autoimmunity 1994b; 19: 239-245 (Authors' Corrigendum in Autoimmunity 1996; 23: 289).
178. Rasmussen ÅK, Kayser L, Brandt M, Bech K, Perrild H, Feldt-Rasmussen U. Human thyroid epithelial cells cultured in monolayers. I. Decreased thyroglobulin and cAMP response to TSH in 12 weeks old secondary and tertiary cultures. Mol Cell Endocrinol 1996a; 116: 165-172.
179. Rasmussen ÅK, Kayser L, Brandt M, Bech K, Perrild H, Feldt-Rasmussen U. Human thyroid epithelial cells cultured in monolayers. II. Influence of serum on thyroglobulin and cAMP production. Mol Cell Endocrinol 1996b; 116: 173-179.
180. Rasmussen ÅK, Diamant M, Blichert-Toft M, Bendtzen K, Feldt-Rasmussen U. The effects of interleukin (IL)-1β on human thyrocyte functions are counteracted by the IL-1 receptor antagonist. Endocrinol 1997; 138: 2043-2048.
181. - cotransporter as a potential autoantigen in thyroid autoimmune disease. Eur J Endocrinol 1995, 132: 399-405.
182. Rayner DC, Lydyard PM, De Assis-Paiva HJ, Bidey S, Van der Meide P, Varey A-M, Cooke A. Interferon-mediated enhancement of thyroid major histocompatibility complex in antigen expression. Scand J Immunol 1987; 25: 621-628.
183. Reimers J, Rasmussen ÅK, Karlsen AE, Bjerre U, Liang H, Morin O, Andersen HU, Mandrup-Poulsen T, Burger A, Feldt-Rasmussen U, Nerup J. Interleukin-1β inhibits rat thyroid cell function in vivo and in vitro by an NO independent mechanism and induces hypothyroidism and accelerated thyroiditis in diabetes-prone BB rats. J Endocrinol 1996; 151: 147-157.
184. Rettori V, Jurcovicova J, McCann SM. Central action of interleukin-1 in altering the release of TSH, growth hormone and prolactin in the male rat. J Neurosci Res 1987; 18: 179-183.
185. Rettori V, Mikenkovic L, Beutler BA, McCann SM. Hypothalamic action of cachectin to alter pituitary hormone release. Brain Res Bull 1989; 23: 471-475.
186. Roman SH, Greenberg D, Rubinstein P, Wallenstein S, Davies TF. Genetics of auto-immune thyroid disease: lack of evidence for linkage to HLA within families. J Clin Endocrinol Metab 1992; 74: 496-503.
187. Roger P, Taton M, Van Sande J, Dumont JE. Mitogenic effects of thyrotropin and adenosine 3′,5′-mono-phosphate in differentiated normal human thyroid cells in vitro. J Clin Endocrinol Metab 1988; 66: 1158-65.
188. Rose NR, Bona C. Defining criteria for autoimmune diseases (Witebsky's postulates revisited). Immunol Today 1993; 14: 426-430.
189. Rutenfranz I, Kruse A, Rink L, Wenzel B, Arnholdt H, Kirchner H. In situ hybridization of the mRNA for interferon-γ, interferon-αE, interferon-β, interleukin-1β and interleukin-6 and characterization of infiltrating cells in thyroid tissues. J Immunol Methods 1992; 148: 233-242.
190. Salvi M, Fukazawa H, Bernard N, Hiromatsu Y, How J, Wall JR. Role of autoantibodies in the pathogenesis and association of endocrine autoimmune disorders. Endocr Rev 1988; 9: 450-466.
191. Salvi M, Girasole G, Pedrazzoni M, Passeri M, Giuliani N, Minelli R, Braverman LE, Roti E. Increased serum concentrations of interleukin-6 (IL-6) and soluble IL-6 receptor in patients with Graves' disease. J Clin Endocrinol Metab 1996; 81: 2976-2979.
192. 125I organification and thyroid hormone release by interleukin-1, tumor necrosis factor-α, and interferon-γ in human thyrocytes in suspension culture. J Clin Endocrinol Metab 1990; 70: 1735-1743.
193. Scalzo S, Gengaro A, Boccoli G, Masciulli R, Giannella G, Salvo G, Marolla P, Carlini P, Massimini G, Holdener EE, Testa U, Calabresi F, Peschle C. Primary hypothyroidism associated with interleukin-2 and interferon-alpha-2 therapy of melanoma and renal carcinoma. Eur J Cancer 1990; 26: 1152-1156.
194. Schultz M, Müller R, Von zur Mühlen A, Brabant G. Induction of hyperthyroidism by interferon-α-2b. Lancet 1989; 1452.
195. Schumm-Draeger PM, Wenisch HJC, Schöffling K. Xenotransplantation of human thyroid tissues in athymic nude mice. In: Growth regulation of thyroid gland and thyroid tumors. Goretski PE & Röher HD (eds). Front Horm Res 1989. 18: 123-136
196. Schwartzentruber DJ, White DE, Zweig MH, Weintraub BD, Rosenberg SA. Thyroid dysfunction associated with immunotherapy for patients with cancer. Cancer 1991; 68: 2384-2390.
197. Semana G, Allanic H, Quillivic F, Vallejo MT, Simon JP, Genet B, Fauchet R. Implication of the HLA-DRB3 gene in Graves' disease, predominance of allele Dw24. Hum Immunol 1990; 29: 143-150.
198. Shalaby MR, Waage A, Espevik T. Cytokine regulation of interleukin 6 production by human endothelial cells. Cell Immunol 1989; 121: 372-382.
199. Shenkman L, Bottone EJ. Antibodies to Yersinia enterocolitica in thyroid disease. Ann Internal Med 1976; 85: 735-739
200. Shi Y, Zou M, Robb D, Farid NR. Typing for major histocompatibility complex class II antigens in thyroid tissue blocks: association of Hashimoto's thyroiditis with HLA-DQA0301 and DQB0201 alleles. J Clin Endocrinol Metab 1992; 75: 943-946.
201. Shields DC, Ratanachaiyavong S, McGregor AM, Collins A, Morton NE. Combined segregation and linkage analysis of Graves' disease with a thyroid autoantibody diathesis. Am J Hum Genet 1994; 55: 540-554.
202. Shirakawa F, Yamashita U, Chedid M, Mizel SB. Cyclic AMP - an intracellular second messenger for interleukin 1. Proc Natl Acad Sci 1988; 85: 8201-8205.
203. Shong M, Ro HK, Kim YK, Yoo CJ, Lee JH, Song CU, Cho BY. The cytokines, interleukin-1β interleukin-6 and interferon-γ upregulate the expression of intercellular adhesion molecule-1 (ICAM-1) in rat thyroid cell line, FRTL-5. Kor J Int Med 1994; 9: 88-92.
204. Spangelo BL, Judd AM, Isakson PC, MacLeod RM. Interleukin-6 stimulates anterior pituitary hormone release in vitro. Endocrinol 1989; 125: 575-577.
205. Stenszky V, Kozma L, Balázs Cs, Rochlitz Ez, Bear JC, Farid NR. The genetics of Graves' disease: HLA and disease susceptibility. J Clin Endocrinol Metab 1985; 61: 735-740.
206. Stenszky V, Balázs C, Kraszits E, Juhasz F, Kozma L, Balázs, Farid NR. Association of goitrous autoimmune thyroiditis with HLA-DR3 in eastern Hungary. J Immunogenetics 1987, 14: 143-148.
207. Sternthal E, Like AA, Braverman IE. Lymphocytic thyroiditis and diabetes in the BB/WW rat. A new model of autoimmune endocrinopathy. Diabetes 1981; 30: 1058-1061.
208. Stouthard JLM, van der Poll T, Endert E, Bakker PJM, Veenhof CHN, Sauerwein HP, Romijn JA. Effects of acute and chronic interleukin-6 administration on thyroid hormone metabolism in humans. J Clin Endocrinol Metab 1994; 79: 1342-1346.
209. Sundick RS, Bagchi N, Brown TR. Mechanisms by which iodine induces autoimmunity. In: Drexhage HA, de Vijlder JIM, Wiersinga WM (eds). The Thyroid Gland, Environment and Autoimmunity. Amsterdam: Elsevier Science Publishers BV, 1990: 13-22.
210. Svenson M, Bendtzen K. Inhibitor of interleukin 1 in normal human urine. Scand J Immunol 1988; 27: 593-599.
211. Svenson M, Kayser L, Hansen MB, Rasmussen ÅK, Bendtzen K. Interleukin 1 receptor on human thyroid cells and on the rat thyroid cell line FRTL 5. Cytokine 1991; 3: 125-130.
212. Svenson M, Hansen MB, Kayser L, Rasmussen ÅK, Reimert CM, Bendtzen K. Effects of human anti-IL-1α autoantibodies on receptor binding and biological activities of IL-1. Cytokine 1992; 4: 125-133.
213. 4 binding without affecting pituitary-thyroid activity in rats. Am J Physiol 1992; 263: E1099-1105.
214. Sztankay A, Trieb K, Lucciarini P, Steiner E, Grubeck-Loebenstein B. Interferon-gamma and iodide increase the inducibility of the 72kD heat shock protein in cultured human thyroid epithelial cells. J Autoimmun 1994; 7: 219-230.
215. Tan GH, Dutton CM, Bahn RS. Interleukin-1 receptor antagonist and soluble interleukin-1 receptor inhibit interleukin-1-induced glycoaminoglycan production in cultured human orbital fibroblasts from patients with Graves' ophthalmopathy. J Clin Endocrinol Metab 1996; 81: 449-452
216. Tandon N, Zhang L, Weetman AP. HLA associations with Hashimoto's thyroiditis. Clin Endocrinol 1991a; 34: 383-386.
217. Tandon N, Dinsdale C, Tamatani T, Miyasaka M, Weetman AP. Adhesion molecule expression by the FRTL-5 rat thyroid cell line. J Endocrinol 1991b; 130: 451-456.
218. Tandon N, Morgan BP, Weetman AP. Expression and function of membrane attack complex inhibitory proteins on thyroid follicular cells. Immunol 1992; 75: 372-377.
219. Tang H, Mignon-Godefroy K, Meroni PL, Garotta G, Charreire J, Nicoletti F. The effects of a monoclonal antibody to interferon-γ on experimental thyroiditis (EAT): prevention of disease and decrease of EAT-specific T cells. Eur J Immunol 1993; 23: 275-278.
220. Tang K-T, Braverman L, DeVito WJ. Tumor necrosis factor-α and interferon-γ modulate gene expression of type I 5′-deiodinase, thyroid peroxidase, and thyroglobulin in FRTL-5 rat thyroid cells. Endocrinol 1995; 136: 881-888.
221. Taverne J, Rayner DC, Van der Meide PH, Lydyard PM, Bidey SP, Cooke A. Cytotoxicity of tumor necrosis factor for thyroid epithelial cells and its regulation by interferon-γ. Eur J Immunol 1987, 17: 1855-1858.
222. Thompson C, Farid NR. Post-partum thyroiditis and goitrous (Hashimoto's) thyroiditis are associated with HLA-DR4*. Immunol Letters 1985; 11: 301-303.
223. Todd I, Pujol-Borrell R, Hammond LJ, Botazzo GF, Feldmann M. Interferon gamma induced HLA-DR expression by thyroid epithelium. Clin Exp Immunol 1985; 61: 265-273.
224. Tolosa E, Roura C, Marti M, Belfiore A, Pujol-Borrell R. Induction of intercellular adhesion molecule-1 but not of lymphocyte function-associated antigen-3 in thyroid follicular cells. J Autoimmun 1992; 5: 119-135.
225. Tomer Y, Davies TF. Infection, thyroid disease, and autoimmunity. Endocrine Rev 1993; 14: 107-120.
226. Tominaga T, Yamashita S, Nagayama Y, Morita S, Yokoyama N, Izumi M, Nagataki S. Interleukin 6 inhibits human thyroid peroxidase gene expression. Acta Endocrinol (Copenh) 1991; 124: 290-294.
227. Van Haasteren GAC, Van der Meer MJM, Hermus ARMM, Linkels E, Klootwijk W, Kaptein E, Van Toor H, Sweep CGJ, Visser TJ, Greef WJ. Different effects of continuous infusion of interleukin-1 and interleukin-6 on the hypothalamic-hypophysial-thyroid axis. Endocrinol 1994; 135: 1336-1345.
228. Van der Poll T, Romijn JA, Wiersinga WM, Sauerwein HP. Tumor necrosis factor: a putative mediator of the sick euthyroid syndrome in man. J Clin Endocrinol Metab 1990; 71: 1567-1572.
229. Van der Poll T, Van Zee KJ, Endert E, Coyle SM, Stiles DM, Fribble JP, Catalano MA, Moldawer LL, Lowry SF. Interleukin-1 receptor blockade does not affect endotoxin-induced changes in plasma thyroid hormone and thyrotropin concentrations in man. J Clin Endocrinol Metab 1995; 80: 1341-1346.
230. Vargas MT, Briones-Urbina R, Gladman D, Papsin FR, Walfish PG. Antithyroid microsomal autoantibodies and HLA-DR5 are associated with postpartum thyroid dysfunction: evidence supporting an autoimmune pathogenesis. J Clin Endocrinol Metab 1988; 67: 327-333.
231. Vassart G, Dumont JE. The thyrotropin receptor and the regulation of thyrocyte function and growth. Endocr Rev 1992; 13: 596-611.
232. Vassilopoulou-Sellin, Sella A, Dexeus FH, Theriault RL, Pololoff DA. Acute thyroid dysfunction (thyroiditis) after therapy with interleukin-2. Horm Metab Res 1992; 24: 434-438.
233. Vertrees S, Wilson CA, Ubungen R, Wilson D, Baskin DG, Toivola B, Jacobs C, Boiani N, Baker P, Lernmark Å. Interleukin-1 beta regulation of islet and thyroid autoimmunity in the BB rat. J Autoimmunity 1991; 4: 717-732.
234. Vialettes B, Guillerand MA, Viens P, Stoppa A-M, Baume D, Sauvan R, Pasquier J, San Marco M, Olive D, Maraninchi D. Incidence rate and risk factors for thyroid dysfunction during recombinant interleukin-2 therapy in advanced malignancies. Acta Endocrinol 1993; 129: 31-38.
235. Volpé R. Autoimmune thyroid disease. In: Volpé R, ed. Autoimmunity and endocrine disease. New York and Basel: Marcel Dekker, Inc. 1985: 195-199.
236. Volpé R, Kasuga Y, Akasu F, Morita T, Yoshikawa N, Resetkova E, Arreaza G. The use of severe combined immunodeficient mouse and the athymic "nude" mouse as models for the study of human autoimmune thyroid disease. Clin Immunol Immunopathol 1993; 67: 93-99.
237. Wang FW, Yu ZQ, Xy JJ, Wang XL, Chen JL. HLA and hypertropic Hashimoto's thyroiditis in Changhai Chines. Tissue Antigens 1988; 32: 235-236.
238. Watson PF, Pickerill AP, Davies R, Weetman P. Analysis of cytokine gene expression in Graves' disease and multinodular goiter. J Clin Endocrinol Metab 1994; 79: 355-360.
239. Watson PF, Pickerill AP, Davies R, Weetman AP. Semi-quantitative analysis of interleukin-1α, interleukin-6 and interleukin-8 mRNA expression by human thyrocytes. J Mol Endocrinol 1995, 15: 11-21.
240. Weetman AP, McGregor AM, Hall R. Evidence for an effect of antithyroid drugs on the natural history of Graves' disease. Clin Endocrinol 1984; 21: 163-172.
241. Weetman AP, Volkman DJm Burman KD, Gerrard TL, Fauci AS. The in vitro regulation of human thyrocyte HLA-DR antigen expression. J Clin Endocrinol Metab 1985; 61: 817-824.
242. 5 thyroid cell line. FEBS Letters 1987; 221: 91-94.
243. Weetman AP, Rees AJ. Synergistic effects of recombinant tumour necrosis factor and interferon-gamma on rat thyroid cell growth and Ia antigen expression. Immunol 1988; 63: 285-289.
244. Weetman AP, Cohen S, Makgoba MW, Borysiewicz LK. Expression of an intercellular adhesion molecule, ICAM-1, by human thyroid cells. J Endocrinol 1989; 122: 185-191.
245. Weetman AP, Bright-Thomas R, Freeman M. Regulation of interleukin-6 release by human thyrocytes. J Endocrinol 1990a; 127: 357-361.
246. Weetman AP, Freeman M, Morgan BP. Thyroid follicular cell function after non-lethal complement membrane attack. Clin Exp Immunol 1990b; 82: 69-74.
247. Weetman AP, Bennett GL, Wong WLT. Thyroid follicular cells produce interleukin-8. J Clin Endocrinol Metab 1992a; 75: 328-330.
248. Weetman AP, Tandon N, Morgan BP. Antithyroid drugs and release of inflammatory mediators by complement-attacked thyroid cells. Lancet 1992b; 340: 633-636.
249. Weetman AP, McGregor AM. Autoimmune thyroid disease: further developments in our understanding. Endocrine Rev 1994; 15: 788-830.
250. Weissel M, Höfer R, Zasmeta H, Mayr WR. HLA-DR and Hashimoto's thyroiditis. Tissue Antigens 1980; 16: 256-257.
251. Westermark K, Nilsson M, Karlsson AF. Effects of interleukin 1 alpha on porcine thyroid follicles in suspension culture. Acta Endocrinol (Copenh) 1990; 122(4): 505-512.
252. Wick G, Brezinschek HP, Hala K, Dietrich H, Wolf H, Kroemer G. The Obese strain of chickens: an animal model with spontaneous autoimmune thyroiditis. Adv Immunol 1989; 47: 433-501.
253. Wiersinga WM. Immunosuppressive treatment of Graves' ophthalmopathy. Thyroid 1992; 2(3): 229-233.
254. Wilson CA, Jacobs C, Baker P, Baskin DG, Dower S, Lernmark Å, Toivola B, Vertrees S, Wilson D. IL-1β modulation of spontaneous autoimmune diabetes and thyroiditis in the BB rat. J Immunol 1990; 144: 3784-3788.
255. Winsa B, Adami H, Bergstrom R, Gamstedt A, Dahlberg P, Adamson U, Jansson R, Karlsson A. Stressful life events and Graves' disease. Lancet 1991; 338: 1475-1479.
256. Yamashita S, Kimura K, Ashizawa Y, Nagayama Y, Hiraya H, Izumi M, Nagataki S. Interleukin-1 inhibits thyrotropin-induced human thyroglobulin gene expression. J Endocrinol 1989; 122: 177-183.
257. 125I incorporation and thyroid hormone release by human thyroid follicles in vitro. J Clin Endocrinol Metab 1993; 77: 1439-1441.
258. Yamazaki K, Yamada E, Kanaji Y, Shizume K, Wang D-S, Maruo N, Obara T, Sato K. Interleukin-6 (IL-6) inhibits thyroid function in the presence of soluble IL-6 receptor in cultured human thyroid follicles. Endocrinol 1996; 139: 4857-4863.
259. Yanagawa T, Mangklabruks A, DeGroot LJ. Strong association between HLA-DQA1*0-501 and Graves' disease in a male vaucasian population. J Clin Endocrinol Metab 1994; 79: 227-229.
260. Yanagawa T, Hidaka Y, Guimaraes V, Soliman M, De Groot LJ. CTLA-4 gene polymorphism associated with Graves' disease in a Caucasian population. J Clin Endocrinol Metab 1995; 80: 41-45.
261. Yip I, Pang X-P, Berg L, Hershman JM. Antitumor actions of interferon-γ and interleukin-1β on human papillary thyroid carcinoma cell lines. J Clin Endocrinol Metab 1995; 80: 1664-1669.
262. Zakarija M, McKenzie JM. Pregnancy-associated changes in thyroid-stimulating antibody of Graves' disease and the relationship to neo-natal hyperthyroidism. J Clin Endocrinol Metab 1983; 57: 1036-1040.
263. Zakarija M, Hornicek FJ, Levis S, McKenzie JM. Effects of γ-interferon and tumor necrosis factor a on thyroid cells: induction of class II antigen and inhibition of growth stimulation. Moll and Cell Endocrinol 1988; 58: 129-136.
264. Zakarija M, McKenzie JM. Influence of cytokines on growth and differentiated function of FRTL5 cells. Endocrinol 1989; 125: 1260-1265.
265. Zeki K, Azuma H, Suzuki H, Morimoto I, Eto S. Effects of interleukin 1 on growth and adenosine 3′,5′-monophosphate generation of the rat thyroid cell line FRTL5 cells. Acta Endocrinol (Copenh) 1991; 124(1): 60-66.
266. Zeki K, Nakano Y, Inokuchi N, Watanabe K, Morimoto I, Yamashita U, Eto S. Autocrine stimulation of interleukin-1 in the growth of human thyroid carcinoma cell line NIM1. J Clin Endocrinol Metab 1993; 76: 127-133.
267. Zheng RQH, Abney E, Chu CQ, Field M, Grubeck-Loebenstein B, Maini RN, Feldmann M. Detection of interleukin-6 and interleukin-1 production in human thyroid epithelial cells by non-radioactive in situ hybridization and immunohisto-chemical methods. Clin Exp Immunol 1991; 83: 314-319.
268. Zheng RQH, Abney ER, Chu CQ, Field M, Maini RN, Lamb JR, Feldmann M. Detection of in vivo production of tumour necrosis factor-alpha by human thyroid epithelial cells. Immunol 1992; 75: 456-462.
269. Zimmermann-Belsing T, Rasmussen ÅK, Feldt-Rasmussen U. Lack of thyroglobulin synthesis as indicator of early dedifferentiation of Fischer rat thyroid cell line, FRTL-5. Scand J Clin Lab Invest 1998; 58: 529-536.